Pharmaron Beijing announces 2024 annual equity distribution

Pharmaron Beijing (SZSE:300759) announced the implementation of its 2024 annual equity distribution plan, approved at the shareholder meeting on June 20, 2025. The company will distribute a cash dividend of CNY 2.00 (inclusive of tax) per 10 shares, totaling approximately CNY 354.19 million (inclusive of tax), based on 1,770,932,225 shares after deducting the repurchased H-shares. The equity registration date is set for July 3, 2025, and the ex-right/ex-dividend date is July 4, 2025. Tax implications vary for different types of shareholders. The grant prices for the company's share incentive plans will be adjusted accordingly.